Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria

被引：39

作者：

Brown-Elliott, BA ^{[1
]}

Wallace, RJ ^{[1
]}

Crist, CJ ^{[1
]}

Mann, L ^{[1
]}

Wilson, RW ^{[1
]}

机构：

[1] Univ Texas Hlth Ctr, Dept Microbiol, Tyler, TX 75708 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 10期

关键词：

D O I：

10.1128/AAC.46.10.3283-3285.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the Mycobacterium fortuitum group at less than or equal to0.12 mug/ml and 90% of the Mycobacterium chelonae isolates at less than or equal to4 mug/ml. Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria.

引用

页码：3283 / 3285

页数：3

共 16 条

[1] Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [J].

Bauernfeind, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) :639-651

[2] ACTIVITIES OF 4 MACROLIDES, INCLUDING CLARITHROMYCIN, AGAINST MYCOBACTERIUM-FORTUITUM, MYCOBACTERIUM-CHELONAE, AND M-CHELONAE-LIKE ORGANISMS [J].

BROWN, BA ;

WALLACE, RJ ;

ONYI, GO ;

DEROSAS, V ;

WALLACE, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) :180-184

[3] Mycobacterium wolinskyi sp nov and Mycobacterium goodii sp nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections:: a cooperative study from the International Working Group on Mycobacterial Taxonomy [J].

Brown, BA ;

Springer, B ;

Steingrube, VA ;

Wilson, RW ;

Pfyffer, GE ;

Garcia, MJ ;

Menendez, MC ;

Rodriguez-Salgado, B ;

Jost, KC ;

Chiu, SH ;

Onyi, GO ;

Böttger, EC ;

Wallace, RJ .

INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1999, 49 :1493-1511

[4] Successful treatment of disseminated Mycobacterium chelonae infection with linezolid [J].

Brown-Elliot, BA ;

Wallace, RJ ;

Blinkhorn, R ;

Crist, CJ ;

Mann, LB .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1433-1434

[5] Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from the SENTRY Antimicrobial Surveillance Program (1997-99) [J].

Jones, RN ;

Pfaller, MA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 39 (04) :237-243

[6]

*NCCLS, 2002, PERF STAND ANT SUS S

[7] PCR AMPLIFICATION AND RESTRICTION-ENDONUCLEASE ANALYSIS OF A 65-KILODALTON HEAT-SHOCK PROTEIN GENE SEQUENCE FOR TAXONOMIC SEPARATION OF RAPIDLY GROWING MYCOBACTERIA [J].

STEINGRUBE, VA ;

GIBSON, JL ;

BROWN, BA ;

ZHANG, YS ;

WILSON, RW ;

RAJAGOPALAN, M ;

WALLACE, RJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :149-153

[8] RAPID DEVELOPMENT OF RESISTANCE TO CLARITHROMYCIN FOLLOWING MONOTHERAPY FOR DISSEMINATED MYCOBACTERIUM-CHELONAE INFECTION IN A HEART-TRANSPLANT PATIENT [J].

TEBAS, P ;

SULTAN, F ;

WALLACE, RJ ;

FRASER, V .

CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) :443-444

[9] RAPID IDENTIFICATION OF MYCOBACTERIA TO THE SPECIES LEVEL BY POLYMERASE CHAIN-REACTION AND RESTRICTION ENZYME ANALYSIS [J].

TELENTI, A ;

MARCHESI, F ;

BALZ, M ;

BALLY, F ;

BOTTGER, EC ;

BODMER, T .

JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (02) :175-178

[10]

Wallace R. J. Jr, 1985, Antimicrobic Newsletter, V2, P85, DOI 10.1016/0738-1751(85)90004-8

← 1 2 →